D R Horton Boosts FY24 Outlook - Update

RTTNews | 33 दिनों पहले
D R Horton Boosts FY24 Outlook - Update

(RTTNews) - While reporting financial results for the second quarter on Thursday, home builder D R Horton Inc. (DHI) raised its revenue and homes closed guidance for the full-year 2024, based on current market conditions and the Company's results for the first half of the year.

For fiscal 2024, the company now projects consolidated revenues in a range of $36.7 billion to $37.7 billion on Homes closed between 89,000 homes and 91,000 homes.

Previously, the company expected consolidated revenues in a range of $36.0 billion to $37.3 billion on Homes closed between 87,000 homes and 90,000 homes.

On average, 17 analysts polled by Thomson Reuters expect the company to report revenues of $36.32 billion for the year.

Subsequent to quarter-end, the Company declared a quarterly cash dividend of $0.30 per common share that is payable on May 9, 2024 to stockholders of record on May 2, 2024.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

टैग: DHI
read more
D R Horton Slashes FY22 Outlook - Update

D R Horton Slashes FY22 Outlook - Update

While reporting financial results for the third quarter on Thursday, home builder D R Horton Inc. (DHI) slashed its revenue and homes closed guidance for the full-year 2022, based on its results for the first nine months of fiscal 2022, expected completion dates of homes under construction and current market conditions.
RTTNews | 670 दिनों पहले
Citius Pharma Announce Positive Topline Results For Pivotal Phase 3 Clinical Trial Of Mino-Lok

Citius Pharma Announce Positive Topline Results For Pivotal Phase 3 Clinical Trial Of Mino-Lok

Biopharmaceutical company Citius Pharmaceuticals, Inc. (CTXR) announced Tuesday positive topline results of its pivotal Phase 3 clinical trial of Mino-Lok, a novel antibiotic lock solution designed to salvage catheters in patients with central line-associated infections (CLABSI) or catheter-related bloodstream infections (CRBSI).
RTTNews | 4घंटे 31 मिनट पहले
European Shares Decline On US Rate Concerns

European Shares Decline On US Rate Concerns

European stocks edged lower on Tuesday following cautious comments from Federal Reserve officials on inflation and the interest rate outlook.
RTTNews | 6घंटे 44 मिनट पहले
Sanofi, OpenAI To Build AI Software To Boost Drug Development

Sanofi, OpenAI To Build AI Software To Boost Drug Development

French drug major Sanofi is teaming with artificial intelligence or AI startup OpenAI, the developer of highly popular generative AI chatbot ChatGPT, as well as Formation Bio, an AI and tech-driven drug developer, to build AI-powered software to accelerate drug development and bring new medicines more efficiently.
RTTNews | 6घंटे 50 मिनट पहले
FTSE 100 Declines On Interest-rate Concerns

FTSE 100 Declines On Interest-rate Concerns

U.K. stock fell on Tuesday following cautious comments from Federal Reserve officials on inflation and the interest rate outlook.
RTTNews | 6घंटे 58 मिनट पहले